Target Name: PALB2
NCBI ID: G79728
Other Name(s): FANCN | mutant partner and localizer of BRCA2 | truncated partner and localizer of BRCA2 | partner and localizer of BRCA2 | PALB2_HUMAN | Fanconi anemia, complementation group N | Partner and localizer of BRCA2 | PNCA3

Palb2: A Protein Regulating The Blood-Brain Barrier and Potential Drug Target

Palb2 (FANCN) is a protein that is expressed in the brain and is involved in the formation of the blood-brain barrier (BBB). The BBB is a specialized barrier that separates the brain from the surrounding blood vessels, and it plays a crucial role in the exchange of nutrients, oxygen, and other substances between the brain and the bloodstream.

Palb2 is a key regulator of the BBB and is involved in the maintenance of its integrity. It helps to regulate the movement of cells through the BBB and ensures that no harmful substances into the brain. Palb2 also plays a role in the regulation of the formation of new blood vessels in the brain, which is important for the delivery of oxygen and nutrients to the brain.

Drug Targeting

Palb2 is a drug target of great interest because of its involvement in the BBB and its role in the regulation of the exchange of substances between the brain and the bloodstream. Drugs that are designed to modulate Palb2 activity have been shown to have a wide range of potential therapeutic applications, including the treatment of various neurological and psychiatric disorders.

One of the main classes of drugs that are currently being developed to target Palb2 is those that modulate the activity ofPalb2 in the brain. These drugs work by either blocking the activity of Palb2 itself or by modulating the activity of other proteins that interact with Palb2.

Another class of drugs that are being developed to target Palb2 are those that modulate the activity of Palb2 in the body as a whole. These drugs work by affecting the levels of Palb2 in the bloodstream or by modulating the activity of other proteins that interact with Palb2.

Biomarker

Palb2 is also of interest as a potential biomarker for the diagnosis and progression of certain neurological disorders. The levels of Palb2 in the brain can be affected by a wide range of factors, including the level of oxygen in the brain, the levels of certain neurotransmitters , and the presence of certain toxins or disease.

By measuring the levels of Palb2 in the brain, researchers can gain insights into the health and function of the brain and develop diagnostic tests for the assessment of neurological disorders. Additionally, Palb2 levels can also be used as a biomarker for the progression of certain disorders. , as the levels of Palb2 in the brain can be affected by the progression of certain diseases.

Conclusion

In conclusion, Palb2 is a protein that is involved in the formation of the blood-brain barrier and plays a crucial role in the maintenance of the integrity of the barrier. Its levels in the brain can be affected by a wide range of factors, including the level of oxygen in the brain, the levels of certain neurotransmitters, and the presence of certain toxins or disease.

Palb2 is also of interest as a potential drug target, due to its involvement in the BBB and its role in the regulation of the exchange of substances between the brain and the bloodstream. Drugs that are designed to modulate Palb2 activity have been shown to have a wide range of potential therapeutic applications, including the treatment of various neurological and psychiatric disorders.

Additionally, Palb2 is also of interest as a potential biomarker for the diagnosis and progression of certain neurological disorders. The levels of Palb2 in the brain can be affected by a wide range of factors, including the level of oxygen in the brain, the levels of certain neurotransmitters, and the presence of certain toxins or disease.

It is important to note that the above information is for general information and not for medical advice.

Protein Name: Partner And Localizer Of BRCA2

Functions: Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks (PubMed:16793542, PubMed:19423707, PubMed:19369211, PubMed:22941656, PubMed:24141787, PubMed:28319063). Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA) (PubMed:20871615). Functionally cooperates with RAD51AP1 in promoting of D-loop formation by RAD51 (PubMed:20871616). Serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex which is essential for homologous recombination (PubMed:19369211). Via its WD repeats is proposed to scaffold a HR complex containing RAD51C and BRCA2 which is thought to play a role in HR-mediated DNA repair (PubMed:24141787). Essential partner of BRCA2 that promotes the localization and stability of BRCA2 (PubMed:16793542). Also enables its recombinational repair and checkpoint functions of BRCA2 (PubMed:16793542). May act by promoting stable association of BRCA2 with nuclear structures, allowing BRCA2 to escape the effects of proteasome-mediated degradation (PubMed:16793542). Binds DNA with high affinity for D loop, which comprises single-stranded, double-stranded and branched DNA structures (PubMed:20871616). May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with BRCA2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity (PubMed:24485656)

More Common Targets

PALD1 | PALLD | PALM | PALM2 | PALM2AKAP2 | PALM3 | PALMD | Palmitoyltransferase | PALS1 | PALS2 | PAM | PAM16 | PAMR1 | PAN2 | PAN3 | PAN3-AS1 | Pancreas transcription factor 1 complex | PANDAR | PANK1 | PANK2 | PANK3 | PANK4 | Pantothenate Kinase | PANTR1 | PANX1 | PANX2 | PANX3 | PAOX | PAPLN | PAPOLA | PAPOLA-DT | PAPOLB | PAPOLG | PAPPA | PAPPA-AS1 | PAPPA-AS2 | PAPPA2 | PAPSS1 | PAPSS2 | PAQR3 | PAQR4 | PAQR5 | PAQR6 | PAQR7 | PAQR8 | PAQR9 | PAR Receptor | PAR-3-PAR-6B-PRKCI complex | Parathyroid Hormone Receptors (PTHR) | PARD3 | PARD3B | PARD6A | PARD6B | PARD6G | PARD6G-AS1 | PARG | PARGP1 | PARK7 | PARL | PARM1 | PARM1-AS1 | PARN | PARP1 | PARP10 | PARP11 | PARP12 | PARP14 | PARP15 | PARP16 | PARP2 | PARP3 | PARP4 | PARP6 | PARP8 | PARP9 | PARPBP | PARS2 | PART1 | PARTICL | PARVA | PARVB | PARVG | Parvovirus initiator complex | PASD1 | PASK | Patatin-like phospholipase domain-containing protein | PATE1 | PATE2 | PATE3 | PATE4 | PATJ | PATL1 | PATL2 | PATZ1 | PAUPAR | PAWR | PAX1 | PAX2 | PAX3 | PAX4